AAO-HNS GUIDELINES Bundle (free trial)

Ménière’s Disease

American Academy of Otolaryngology-Head and Neck Surgery Foundation GUIDELINES Apps brought to you free pf charge, courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1226253

Contents of this Issue


Page 1 of 21

2 Key Points ➤ Ménière's disease (MD) is a clinical syndrome affecting approximately 50–200/100,000 adults and is most common between the ages of 40–60. ➤ The diagnosis of MD is made clinically since the disease typically presents with unilateral ear symptoms that can last for several decades. MD attacks are typically random and episodic (approximately 6–11/year), with periods of remission that may last months to years. • As such, the diagnosis of MD is typically not made at one point in time; rather it may take months or even years to fully appreciate the clinical manifestations leading to definitive diagnosis. ➤ The natural course of MD is typically progressive and fluctuates unpredictably. ➤ It is important to clinically distinguish MD from other independent causes of vertigo such as otosyphilis, vestibular neuritis and acute labyrinthitis that may mimic MD since they also present with hearing loss, tinnitus, and aural fullness. ➤ The goals of MD treatment are to prevent or at least reduce the severity and frequency of vertigo attacks. In addition, treatment approaches aim to relieve or prevent hearing loss, tinnitus, and aural fullness and to improve overall quality of life.

Articles in this issue

Archives of this issue

view archives of AAO-HNS GUIDELINES Bundle (free trial) - Ménière’s Disease